Redeye makes downward estimate revisions on the back of I-Tech’s Q4 figures, as sales were slightly postponed, and costs grew more than expected. The underlying customer pipeline continues to progress, most recently by signing a contract with Akzo in
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/
© Modular Finance, source